Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 147 results for "Emixustat Hydrochloride"

1 images for "Emixustat Hydrochloride"

Securities Technology Monitor, 2 months ago

New market study, "Retinopathy Of Prematurity - Pipeline Review, H2 2014", has been published

Global Markets Direct's, 'Retinopathy Of Prematurity - Pipeline Review, H2 2014', provides an overview of the Retinopathy Of Prematurity's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ...
 Tamar Securities3 weeks ago

Research and Markets Adds Report: Retinopathy Of Prematurity - Pipeline Review, H2 2014

Research and Markets has announced the addition of the "Retinopathy Of Prematurity - Pipeline Review, H2 2014" report to its offerings. In a release, Research and Markets noted that report highlights include: This report provides comprehensive ...
 Individual.com1 month ago

Acucela Inc lowers consolidated full-year outlook for FY 2014

6:30pm EST Acucela Inc:Says the company lowered the consolidated full-year outlook for revenue to $34,739,000 from $61,840,000 for FY ending Dec. 2014.Sees a decrease of operating profit forecast to $693,000 from $836,000.Sees an increase of ...
 Reuters1 month ago

Global Retinopathy Of Prematurity Therapeutics Pipeline Review, H2 2014 - Analysis of 6 Companies & 8 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/tdsmfd/retinopathy_of) has announced the addition of the "Retinopathy Of Prematurity - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive ...
 Individual.com1 month ago Global Diabetic Retinopathy Therapeutics Pipeline Report H2 2014 - Analysis of 28 Companies & 44 Drug Profiles  Individual.com1 month ago Research and Markets: Global Retinopathy Of Prematurity Therapeutics Pipeline Review, H2 2014 - Analysis of 6 Companies & 8 Drug Profiles  BioMedReports1 month ago RESEARCH AND MARKETS : Global Retinopathy Of Prematurity Therapeutics Pipeline Review, H2 2014 - Analysis of 6 Companies & 8 Drug Profiles  4 Traders1 month ago
[x]  

Physician-Reported Patient Share for Bayer's Eylea in the EU5 Wet Age-Related Macular Degeneration Market Has Increased Significantly Over the Past Year

BURLINGTON, Mass. , Oct. 27, 2014 /PRNewswire/ --Decision Resources Group finds that retinal specialists in the EU5 ( France , Germany , Italy , Spain , and the United Kingdom ) report patient share for Bayer's Eylea, the most recently launched ...
 RCL Advisors1 month ago The Age-Related Macular Degeneration Drug Market Will Grow to Nearly $9 Billion in 2023, Fueled in Part by the Anticipated Launch of the First Therapies for Geographic Atrophy  Wall Street Business Network2 months ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less